Caerulein, sulfated
SKU: 02152860-CF
Caerulein, Sulfated
Application Notes
Caerulein is used to study cell signaling mediated by NF-kappaB upregulation of proteins such as intercellular adhesion molecule-1(ICAM-1) and inflammation related molecules such as NADPH oxidase and Janus kinase signal transducer. It prevents gall bladder pain, renal colic, and the pain of intermittent claudication.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Used to study cell signaling mediated by NF-kappaB upregulation of proteins such as intercellular adhesion molecule-1(ICAM-1) and inflammation related molecules such as NADPH oxidase and Janus kinase signal transducer
| SKU | 02152860-CF |
| Alternate Names | pyroGlu-Gln-Asp-Tyr[SO3H]-Thr- Gly-Trp-Met-Asp-Phe-NH2; Caerulein Sulfated; Cerulein; Ceruletide; [Tyr(SO3H)4]Caerulein |
| Application Notes | Caerulein is used to study cell signaling mediated by NF-kappaB upregulation of proteins such as intercellular adhesion molecule-1(ICAM-1) and inflammation related molecules such as NADPH oxidase and Janus kinase signal transducer. It prevents gall bladder pain, renal colic, and the pain of intermittent claudication. |
| Base Catalog Number | 152860 |
| Beilstein Registry Number | 5422487 |
| Biochemical Physiological Actions | It is seen as an antagonist of endogenous opioids. |
| CAS # | 17650-98-5 |
| Format | Powder |
| Molecular Formula | C58H73N13O21S2 |
| Molecular Weight | 1352.412 g/mol |
| Personal Protective Equipment | Eyeshields, Gloves, respirator filter |
| Preparation Method | The peptide is to be dissolved in distilled, oxygen free or preferable sterile oxygen free water first. The concentration should be high enough to allow addition of buffer after the products is dissolved completely. If necessary diluted acetic acid or ammonium hydroxide, app. 1%, can be added to help solubilize the peptide. In those rare cases where solubilization is still not achieved, the solution may be sonicated briefly (up to 10 min, temperature shouldn't rise over 30-40 °C). In order to avoid serious solubility problems, buffer or saline should be added after the peptide is fully in solution. |
| Solubility | 1.16e-02 g/L |
| Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |